Clinical trial

Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors

NCT03453528

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention 68Ga-PSMA Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-07-04

PhaseNA

Conditions

Prostate-specific Membrane Antigenunresolved

mCRPC or Advanced/Metastatic Solid Tumorsunresolved

Interventions

68Ga-PSMADRUG

Sponsors & collaborators

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03453528 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.